A North Olmsted man has been charged in federal court with selling misbranded drugs, according to a recent indictment.
Khaled Farouk Elgayar, 50, allegedly sold erectile dysfunction treatments that contained undeclared ingredients, including sildenafil, which is the active ingredient in FDA-approved prescription drugs used to treat erectile dysfunction.
The labels of the products Elgayar sold failed to include the name and quantity of the drug ingredient, posing serious potential side effects or harm to consumers with certain pathological conditions.
Elgayar received misbranded drugs and delivered or proffered delivery of those misbranded drugs between January and October 2016, according to the indictment.
The case is being prosecuted by Assistant U.S. Attorneys Megan R. Miller and Michael L. Collyer following an investigation by the Food and Drug Administration.
An information is only a charge and is not evidence of guilt. A defendant is entitled to a fair trial in which it will be the government’s burden to prove guilt beyond a reasonable doubt.
The matter is ongoing, and the court will determine the defendant’s sentence after review of factors unique to this case, including the defendant’s prior criminal record, if any, the defendant’s role in the offense, and the characteristics of the violations.
Key Facts
- State: Ohio
- Category: Drug Trafficking|Fraud & Financial Crimes|Violent Crime
- Source: DOJ Press Release â†â€â€
ðŸâ€Â’ Get the grimiest stories delivered weekly. Subscribe free →
